Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sponsors Rein In Clinical Trial Violation Rate, But Monitoring Is Problematic

This article was originally published in The Gray Sheet

Executive Summary

Despite improvements in sponsors' compliance with clinical trial regulations last year, trial monitoring continues to be an issue, according to CDRH

You may also be interested in...



FDA Urges Centralized Clinical Trial Monitoring Over Frequent On-Site Visits – Guidance

Clinical trial sponsors should make greater use of off-site centralized monitoring, in place of frequent on-site visits, to ensure the quality of their trials, FDA emphasizes in new draft guidance.

FDA Urges Centralized Clinical Trial Monitoring Over Frequent On-Site Visits – Guidance

Clinical trial sponsors should make greater use of off-site centralized monitoring, in place of frequent on-site visits, to ensure the quality of their trials, FDA emphasizes in new draft guidance.

Device Research Compliance Is On Positive Trend – FDA Official

Device companies and other organizations involved in device research have made significant improvements in recent years in complying with FDA research regulations, an agency official said last week.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel